Kabi Holds To US Prices Even As Injectables Volumes Slip

 
• By Aidan Fry
  
Dollars
Fresenius Kabi is determined to hold stable its prices for US generic injectables, even if it means sacrificing some volume • Source: Shutterstock

More from Earnings

More from Business